Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of AnaptysBio Inc (NASDAQ: ANAB) closed at $16.18 in the last session, down -4.15% from day before closing price of $16.88. In other words, the price has decreased by -$4.15 from its previous closing price. On the day, 1.96 million shares were traded. ANAB stock price reached its highest trading level at $17.0999 during the session, while it also had its lowest trading level at $16.06.
Ratios:
We take a closer look at ANAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.23 and its Current Ratio is at 10.23. In the meantime, Its Debt-to-Equity ratio is 4.35 whereas as Long-Term Debt/Eq ratio is at 4.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on December 11, 2024, Downgraded its rating to Neutral and sets its target price to $19 from $52 previously.
On July 22, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $55.H.C. Wainwright initiated its Buy rating on July 22, 2024, with a $55 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 30 ’24 when EcoR1 Capital, LLC bought 65,184 shares for $12.92 per share. The transaction valued at 842,060 led to the insider holds 7,860,180 shares of the business.
EcoR1 Capital, LLC bought 13,268 shares of ANAB for $171,513 on Dec 31 ’24. The Director now owns 7,873,448 shares after completing the transaction at $12.93 per share. On Jan 02 ’25, another insider, EcoR1 Capital, LLC, who serves as the Director of the company, bought 6,646 shares for $12.95 each. As a result, the insider paid 86,070 and bolstered with 7,880,094 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 492336384 and an Enterprise Value of 429277088. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.61 while its Price-to-Book (P/B) ratio in mrq is 5.84. Its current Enterprise Value per Revenue stands at 7.509 whereas that against EBITDA is -3.078.
Stock Price History:
The Beta on a monthly basis for ANAB is -0.00, which has changed by -0.2853514 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, ANAB has reached a high of $41.31, while it has fallen to a 52-week low of $12.51. The 50-Day Moving Average of the stock is -11.48%, while the 200-Day Moving Average is calculated to be -39.12%.
Shares Statistics:
According to the various share statistics, ANAB traded on average about 674.43K shares per day over the past 3-months and 674990 shares per day over the past 10 days. A total of 30.43M shares are outstanding, with a floating share count of 25.91M. Insiders hold about 14.86% of the company’s shares, while institutions hold 103.47% stake in the company. Shares short for ANAB as of 1735603200 were 7326087 with a Short Ratio of 10.86, compared to 1732838400 on 7099413. Therefore, it implies a Short% of Shares Outstanding of 7326087 and a Short% of Float of 32.880002000000005.
